WO1996001799A1 - Oligohydroxydicarboxylic acid derivatives - Google Patents
Oligohydroxydicarboxylic acid derivatives Download PDFInfo
- Publication number
- WO1996001799A1 WO1996001799A1 PCT/EP1995/002563 EP9502563W WO9601799A1 WO 1996001799 A1 WO1996001799 A1 WO 1996001799A1 EP 9502563 W EP9502563 W EP 9502563W WO 9601799 A1 WO9601799 A1 WO 9601799A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- oligohydroxydicarboxylic
- formula
- carbon atoms
- linear
- Prior art date
Links
- 239000002253 acid Substances 0.000 title claims abstract description 37
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 21
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 15
- 230000004888 barrier function Effects 0.000 claims abstract description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000001257 hydrogen Substances 0.000 claims abstract description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000001301 oxygen Substances 0.000 claims abstract description 9
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 9
- 150000002632 lipids Chemical class 0.000 claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims description 12
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 claims description 9
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 claims description 8
- 150000007513 acids Chemical class 0.000 claims description 7
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 150000002191 fatty alcohols Chemical class 0.000 claims description 5
- 125000005907 alkyl ester group Chemical group 0.000 claims description 4
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- 229910014033 C-OH Inorganic materials 0.000 claims description 2
- 229910014570 C—OH Inorganic materials 0.000 claims description 2
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- 239000001358 L(+)-tartaric acid Substances 0.000 claims description 2
- 235000011002 L(+)-tartaric acid Nutrition 0.000 claims description 2
- FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 229940048879 dl tartaric acid Drugs 0.000 claims description 2
- AUONNNVJUCSETH-UHFFFAOYSA-N icosanoyl icosanoate Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCCCCCC AUONNNVJUCSETH-UHFFFAOYSA-N 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 6
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- -1 fatty acyl radical Chemical class 0.000 description 22
- 239000000203 mixture Substances 0.000 description 21
- 210000003491 skin Anatomy 0.000 description 17
- 150000001412 amines Chemical class 0.000 description 10
- 229940106189 ceramide Drugs 0.000 description 8
- 150000001783 ceramides Chemical class 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- XUJLWPFSUCHPQL-UHFFFAOYSA-N 11-methyldodecan-1-ol Chemical compound CC(C)CCCCCCCCCCO XUJLWPFSUCHPQL-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- FIPPFBHCBUDBRR-UHFFFAOYSA-N henicosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCO FIPPFBHCBUDBRR-UHFFFAOYSA-N 0.000 description 2
- FVDRFBGMOWJEOR-UHFFFAOYSA-N hexadecan-2-ol Chemical compound CCCCCCCCCCCCCCC(C)O FVDRFBGMOWJEOR-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- SJWFXCIHNDVPSH-UHFFFAOYSA-N octan-2-ol Chemical compound CCCCCCC(C)O SJWFXCIHNDVPSH-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- JXNPEDYJTDQORS-HZJYTTRNSA-N (9Z,12Z)-octadecadien-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCO JXNPEDYJTDQORS-HZJYTTRNSA-N 0.000 description 1
- IKYKEVDKGZYRMQ-PDBXOOCHSA-N (9Z,12Z,15Z)-octadecatrien-1-ol Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCO IKYKEVDKGZYRMQ-PDBXOOCHSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- QDTDKYHPHANITQ-UHFFFAOYSA-N 7-methyloctan-1-ol Chemical compound CC(C)CCCCCCO QDTDKYHPHANITQ-UHFFFAOYSA-N 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000186892 Aloe vera Species 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- VPIDXLJVGVBFOW-UHFFFAOYSA-N C=1C=[C-]PC=1 Chemical class C=1C=[C-]PC=1 VPIDXLJVGVBFOW-UHFFFAOYSA-N 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 150000001723 carbon free-radicals Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- 150000001784 cerebrosides Chemical class 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- BHYOQNUELFTYRT-DPAQBDIFSA-N cholesterol sulfate Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 BHYOQNUELFTYRT-DPAQBDIFSA-N 0.000 description 1
- 229940080277 cholesteryl sulfate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- JXNPEDYJTDQORS-UHFFFAOYSA-N linoleyl alcohol Natural products CCCCCC=CCC=CCCCCCCCCO JXNPEDYJTDQORS-UHFFFAOYSA-N 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- NQYKSVOHDVVDOR-UHFFFAOYSA-N n-hexadecylhexadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCNCCCCCCCCCCCCCCCC NQYKSVOHDVVDOR-UHFFFAOYSA-N 0.000 description 1
- SZEGKVHRCLBFKJ-UHFFFAOYSA-N n-methyloctadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCNC SZEGKVHRCLBFKJ-UHFFFAOYSA-N 0.000 description 1
- HKUFIYBZNQSHQS-UHFFFAOYSA-N n-octadecyloctadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCNCCCCCCCCCCCCCCCCCC HKUFIYBZNQSHQS-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- ALSTYHKOOCGGFT-UHFFFAOYSA-N octadec-9-en-1-ol Chemical compound CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ALSTYHKOOCGGFT-MDZDMXLPSA-N oleyl alcohol Chemical compound CCCCCCCC\C=C\CCCCCCCCO ALSTYHKOOCGGFT-MDZDMXLPSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000012186 ozocerite Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical compound NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
Definitions
- the invention relates to oligohydroxydicarboxylic acid derivatives which are obtainable by reacting oligohydroxydicarboxylic acids or their esters with fatty alcohols and / or fatty amines, a process for the preparation of the oligohydroxycarboxylic acid derivatives, skin care products containing the oligohydroxydicarboxylic acid derivatives and the use of the oligohydroxy-derived carboxylic acid derivatives.
- a balanced water balance in the individual skin layers plays an important role for the elasticity and appearance of the skin.
- the amount of bound water is greatest in the Dennis and in the boundary layer of the epidermis near the basement membrane.
- the skin elasticity is decisively shaped by the collagen fibrils in the Dennis, the specific conformation of the collagen being achieved by the incorporation of water molecules.
- Destruction of the lipid barrier in the stratum corneum (SC), for example by surfactants leads to an increase in the transepidermal water loss, as a result of which the aqueous environment of the cells is disturbed. Because that in deeper Water bound to the skin layers can only be supplied via the body fluid via vessels, but not from the outside, it becomes clear that maintaining the barrier function of the stratum corneum is essential for the overall condition of the skin. [see. SE Friberg et al., CR 23rd CED Congress, Barcelona, 1992, p.29].
- Ceramides are lipophilic amides of long-chain fatty acids, which are generally derived from sphingosine or phytosphingosine. This class of endogenous fatty substances has gained considerable importance since they have been recognized in the intercellular space between the corneocytes as key components for the structure of the lipid bilayer, ie the permeability barrier, in the stratum corneum of human skin. Ceramides have molecular weights of significantly less than 1000, so that the external location in a cosmetic formulation makes it possible to reach the site of action. The external application of ceramides leads to the restoration of the lipid barrier, as a result of which the described disorders of the skin function can be counteracted. [see. R.D. Petersen, Cosm. Toil. 107, 45 (1992)].
- R a stands for hydrogen or an unsaturated fatty acyl radical
- z for numbers from 7 to 49
- R- ° for a hydroxyalkyl
- Z for a sugar or phosphate radical
- the object of the present invention is to develop new high-performance ceramide-analog structures which are distinguished by the simplest possible synthesis. Another task is to create new connections with one another Manufacture structure that comes very close to ceramides or pseudoceramides on the basis of non-animal raw materials.
- the invention relates to oligohydroxycarboxylic acid derivatives of the formula I.
- Oligohydroxydicarboxylic acid derivatives of the formula I are particularly preferred, in which R 1 and R 2 are identical or different and for a linear or branched alkyl and / or alkenyl radical having 12 to 22 carbon atoms, X 1 and X 2 for oxygen, R 3 for a hydroxyl group and n stand for a number of 4.
- the invention further relates to a process for the preparation of oligohydroxydicarboxylic acid derivatives of the formula I.
- X x and X 2 are the same or different and for oxygen or an NR ⁇ group, in which R * * is hydrogen or a linear or branched alkyl radical having 1 to 30 carbon atoms, R 3 is hydrogen or a hydroxyl group and n is a number from 1 to 5, with the proviso that that when n is 1, R 3 is a hydroxy group, which is characterized in that
- R 3 and n have the meaning given above, or a reactive derivative thereof, in a manner known per se with compounds of the formula III and / or IV
- Suitable oligohydroxydicarboxylic acids which come under general formula II are those having 3 to 7 carbon atoms and 1 to 5 hydroxyl groups. Typical examples are tartronic acid, malic acid, D - (-) - tartaric acid, L - (+) - tartaric acid, DL-tartaric acid, glucaric acid, mucic acid, mannosugaric acid, arabinosugaric acid or heptaglucaric acid.
- the dicarboxylic acids themselves or their reactive derivatives are used. Lactones and C1-C4-alkyl esters are particularly suitable as reactive carboxylic acid derivatives.
- the corresponding dicarboxamides ie when X 1 and / or X 2 represent an NR ⁇ group, it is particularly advantageous to convert the oligohydroxydi carboxylic acids into the corresponding C 4 -C 4 alkyl esters.
- These esters can be obtained in a manner known per se by esterifying the acids in the C 1 -C 4 alcohols in the presence of a catalyst.
- the oligohydroxydicarboxylic acids or their reactive derivatives are reacted in a manner known per se with compounds of the formulas III and / or IV, it being possible for the compounds of the formulas III and IV to be identical or different.
- the amount of compounds III and IV is usually selected so that in the end product with the formula I at least one of R 1 or R 2 is a carbon radical having more than 6, preferably more than 12, carbon atoms.
- the oligohydroxydicarboxylic acids or their reactive derivatives and the compounds of the formulas III and / or IV are used in a molar ratio of 1: 0.9 to 1: 2.2.
- Either alcohols, ie when X 1 and X 2 are oxygen, or amines, ie when X 1 and X 2 are a group NR * *, can be used as compounds with the formulas III and IV.
- Alcohols with the formula R — OH and R 2 OH are in particular those in which R 1 and R 2 are linear or branched alkyl and / or alkenyl radical having 12 to 22 carbon atoms.
- suitable alcohols are 1-, 2-hexadecanol, 1-octadecanol, 9-octadecen-l-ol, 1-tetradecanol, 1-dodecanol, 1-isononol, 1-isotridecanol, 1-octanol , 2-octanol, hexanol, 1-eicosanol, 1-heneicosanol, 1-docosanol, 1-nonanol, 1-isononanol, 1-isotridecanol, 1-iso-octadecanol, particularly suitable.
- suitable alcohols are, for example, the native fatty alcohols based on plants, such as lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol, behen alcohol, oleyl alcohol, elaidyl alcohol, ricinol alcohol, linoleyl alcohol, linolenyl alcohol and their technical mixtures, such as coconut oil alcohol, palm fat and palm alcohol or also natural alcohol.
- Particularly suitable amines with the compounds HNR 1 R 4 and HNR 2 R 4 are alkylamines, in which R 2 is a linear or branched alkyl and / or alkenyl radical having 12 to 22 carbon atoms and R 4 is hydrogen or a linear one or branched alkyl radical having 1 to 22 carbon atoms, so-called fatty amines.
- Examples include fatty amines, especially primary fatty alkylamines, such as hexadecylamine, octadecylamine, dodecylamine, decylamine or octylamine, but also dialkylamines, such as dioctadecylamine, dihexadecylamine, and Guerbetamines, such as.
- fatty amines especially primary fatty alkylamines, such as hexadecylamine, octadecylamine, dodecylamine, decylamine or octylamine, but also dialkylamines, such as dioctadecylamine, dihexadecylamine, and Guerbetamines, such as.
- methyloctadecylamine can be called.
- As a technical Fatty amines in particular those based on plants, such as coconut amine, palm kernel amine or
- the condensation reaction is preferably carried out at temperatures in the range from 20 to 95 ° C. in the presence of a suitable catalyst, the reaction times typically being up to 24 hours.
- a suitable catalyst such as NaOH, KOH, CH3 ⁇ Na, C2HsONa and acidic catalysts such as H2SO4, p-toluenesulfonic acid, methanesulfonic acid, phosphoric acid or amidosulfonic acid are used for the transesterification of the lower alkyl esters with fatty alcohols.
- suitable solvents are gasoline fractions, 1,2-dimethoxyethane, acetone, butanone, tert-butyl methyl ether or tetrahydrofuran.
- the invention further relates to skin care compositions containing oligohydroxydicarboxylic acid derivatives of the formula I.
- compositions according to the invention can contain the oligohydroxydicarboxylic acid derivatives in amounts of 1 to 50, preferably 1 to 30, in particular 2 to 10% by weight, based on the composition, both as “water-in-oil” and “oil-in-water” emulsions are present; further conventional auxiliaries and additives can be present in amounts of 5 to 95, preferably 10 to 80,% by weight.
- the formulations can contain water in an amount of up to 99% by weight, preferably 5 to 80% by weight.
- Suitable carrier oils include, for example: mineral oils, vegetable oils, silicone oils, fatty acid esters, dialkyl ethers, fatty alcohols and Guerbet alcohols.
- emulsifiers examples include: sorbitan esters, monoglycerides, polysorbates, polyethylene glycol mono / difatty acid esters, highly ethoxylated fatty acid esters and high molecular weight silicone compounds, such as dimethylpolysiloxanes with an average molecular weight of 10,000 to 50,000.
- Other additives can be: preservatives such as p-hydroxybenzoic acid ester; Antioxidants, such as butylated hydroxytoluene, tocopherol: humectants, such as glycerol, sorbiol.
- the oligohydroxydicarboxylic acid derivatives can be mixed with conventional ceramides, pseudoceramides, cholesterol, cholesterol fatty acid esters, fatty acids, triglycerides, cerebrosides, phospholipids and similar substances, liposomes being formed.
- the oligohydroxydicarboxylic acid derivatives can be mixed with accelerators, in particular with essential oils, such as eucalyptol, menthol and the like.
- the oligohydroxydicarboxylic acid derivatives can finally also be dissolved in squalene or squalane and optionally formulated with the other ingredients mentioned together with volatile or non-volatile silicone compounds as anhydrous or almost anhydrous single-phase systems.
- squalene or squalane optionally formulated with the other ingredients mentioned together with volatile or non-volatile silicone compounds as anhydrous or almost anhydrous single-phase systems.
- constituents and typical compositions can be found, for example, in WO 90/01323 (Bernstein) and SE Friberg, J. Soc. Co ⁇ et. Chem. 41, 155 (1990).
- oligohydroxydicarboxylic acid derivatives to be used as "synthetic barrier lipids" in the sense of the invention strengthen the natural barrier function of the skin against external stimuli. They improve the firmness, suppleness and elasticity of the skin, increase the moisture content and protect the skin from drying out; at the same time, the finest wrinkles are smoothed out.
- Another object of the invention therefore relates to the use of oligohydroxydicarboxylic acid derivatives of the formula I as "synthetic barrier lipids" for the production of skin care products in which they are used in amounts of 1 to 50, preferably 1 to 30, in particular 2 to 10 % By weight, based on the composition, may be present.
- synthetic barrier lipids for the production of skin care products in which they are used in amounts of 1 to 50, preferably 1 to 30, in particular 2 to 10 % By weight, based on the composition, may be present.
- special formulations which form liquid-crystalline, lamellar structures are also particularly advantageous for maintaining the barrier function of the skin.
- formulations can be based on the composition of the horny layer lipids as main components 5% by weight to 50% by weight of a compound with the formula I, 25% by weight to 75% by weight of saturated and unsaturated fatty acids, their alkali metal salts or mixtures of the Fatty acids and their salts, 10% by weight to 50% by weight of cholesterol, phytosterols and / or cholesteryl sulfate, 5% by weight to 30% by weight of triglycerides (triolein) and wax esters, and 2% by weight.
- triglycerides triolein
- triolein triolein
- triolein triolein
- wax esters 2% by weight.
- -% to 20 wt .-% phospholides such as lecithins or kephalins contain.
- Typical examples of such formulations are skin creams, soft creams, nutritional creams, sunscreen creams, night creams, skin oils, skin care lotions and body aerosols.
- a mixture of 64.5 g (0.2 mol) of mucic acid dibutyl ester, 119.4 g (0.4 mol) of the equimolar mixture of octadecanol and docosanol and 0.5 g of p-toluenesulfonic acid was at 90 ° C. under pressure for 12 hours of 50 mbar, heated, butanol formed was distilled off at the same time.
- the reaction mixture was dissolved in acetone, stirred with 0.3 g of sodium carbonate and filtered. The filtrate was evaporated and dried. 146 g (95% of theory) of a beige-colored product which had a melting point of 59-88 ° C. were obtained.
- a mixture of 64.5 g (0.2 mol) of mucic acid dibutyl ester, 102.6 g (0.4 mol) of the equimolar mixture of hexadecanol and octadecanol was prepared analogously to Example 2b.
- a colorless waxy product with a melting point of 100-112 ° C. was obtained.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
New oligohydroxycarboxylic acid derivatives having the formula (I) are described. In formula (I), R1 stands for a linear or branched alkyl and/or alkenyl residue with 6 to 30 carbon atoms, R2 stands for a linear or branched alkyl and/or alkenyl residue with 1 to 30 carbon atoms, X?1 and X2¿ are the same or different and stand for oxygen or a NR4 group, in which R4 stands for oxygen or a linear or branched alkyl residue with 1 to 30 carbon atoms, R3 stands for hydrogen or a hydroxyl group and n equals 1 to 5, provided that when n equals 1, R3 be a hydroxyl group. These substances are suitable as synthetic barrier lipids for skin care products.
Description
Oligohydroxydicarbonsäurederivate Oligohydroxydicarboxylic acid derivatives
Gebiet der ErfindiinσField of Invention
Die Erfindung betrifft Oligohydroxydicarbonsäurederivate, die erhältlich sind durch Umsetzung von Oligohydroxydicarbonsäuren bzw. deren Estern mit Fettalkoholen und/oder Fettaminen, ein Verfahren zur Herstellung der Oligohydroxycarbonsäurederivate, Hautpflegemittel mit einem Gehalt der Oligohydroxydicarbon- säurederivate sowie die Verwendung der Oligohydroxycarbonsäu- rederivate zur Herstellung von Hautpflegemitteln.The invention relates to oligohydroxydicarboxylic acid derivatives which are obtainable by reacting oligohydroxydicarboxylic acids or their esters with fatty alcohols and / or fatty amines, a process for the preparation of the oligohydroxycarboxylic acid derivatives, skin care products containing the oligohydroxydicarboxylic acid derivatives and the use of the oligohydroxy-derived carboxylic acid derivatives.
Stand der TechnikState of the art
Für die Elastizität und das Aussehen der Haut spielt ein aus¬ balancierter Wasserhaushalt in den einzelnen Hautschichten ei¬ ne wichtige Rolle. In der Dennis und in der Grenzschicht der Epidermis nahe der Basalmembran ist der Gehalt an gebundenem Wasser am größten. Die Hautelastizität wird entscheidend durch die Kollagenfibrillen in der Dennis geprägt, wobei die spezi¬ fische Konformation des Kollagens durch den Einbau von Wasser¬ molekülen erreicht wird. Eine Zerstörung der Lipid-Barriere im Stratum Corneum (SC) beispielsweise durch Tenside führt zu ei¬ nem Anstieg des transepidermalen Wasservelustes, wodurch die wäßrige Umgebung der Zellen gestört wird. Da das in tieferen
Hautschichten gebundene Wasser nur über Gefäße über die Kör¬ perflüssigkeit, nicht aber von außen zugeführt werden kann, wird deutlich, daß der Erhalt der Barrierefunktion des Stratum Corneum essentiell für den Gesamtzustand der Haut ist. [vgl. S.E. Friberg et al., C.R. 23. CED-Kongress, Barcelona, 1992, S.29].A balanced water balance in the individual skin layers plays an important role for the elasticity and appearance of the skin. The amount of bound water is greatest in the Dennis and in the boundary layer of the epidermis near the basement membrane. The skin elasticity is decisively shaped by the collagen fibrils in the Dennis, the specific conformation of the collagen being achieved by the incorporation of water molecules. Destruction of the lipid barrier in the stratum corneum (SC), for example by surfactants, leads to an increase in the transepidermal water loss, as a result of which the aqueous environment of the cells is disturbed. Because that in deeper Water bound to the skin layers can only be supplied via the body fluid via vessels, but not from the outside, it becomes clear that maintaining the barrier function of the stratum corneum is essential for the overall condition of the skin. [see. SE Friberg et al., CR 23rd CED Congress, Barcelona, 1992, p.29].
Ceramide stellen liphophile Amide langkettiger Fettsäure dar, die sich im allgemeinen von Sphingosin bzw. Phytosphingosin ableiten. Erhebliche Bedeutung hat diese Klasse von körperei¬ genen Fetstoffen gewonnen, seitdem man sie im interzellulären Raum zwischen den Corneozyten als Schlüsselkomponenten für den Aufbau des Lipid-Bilayers, also der Permeabilitätsbarriere, im Stratum Corneum der menschlichen Haut erkannt hat. Ceramide haben Molekulargewichte von deutlich unter 1000, so daß bei äußerer Zufuhr in einer kosmetischen Formulierung das Errei¬ chen des Wirkortes möglich ist. Die externe Applikation von Ceramiden führt zur Restaurierung der Lipidbarriere, wodurch den geschilderten Störungen der Hautfunktion ursächlich entge¬ gengewirkt werden kann. [vgl. R.D. Petersen, Cosm. Toil. 107, 45 (1992)].Ceramides are lipophilic amides of long-chain fatty acids, which are generally derived from sphingosine or phytosphingosine. This class of endogenous fatty substances has gained considerable importance since they have been recognized in the intercellular space between the corneocytes as key components for the structure of the lipid bilayer, ie the permeability barrier, in the stratum corneum of human skin. Ceramides have molecular weights of significantly less than 1000, so that the external location in a cosmetic formulation makes it possible to reach the site of action. The external application of ceramides leads to the restoration of the lipid barrier, as a result of which the described disorders of the skin function can be counteracted. [see. R.D. Petersen, Cosm. Toil. 107, 45 (1992)].
Dem Einsatz von Ceramiden sind infolge ihrer mangelnden Ver¬ fügbarkeit bislang Grenzen gesetzt. Es hat daher bereits Ver¬ suche gegeben, ceramidanaloge Strukturen, sogenannte "synthetic barrier lipids (SBL)" oder "Pseudoceramide" zu syn¬ thetisieren und zur Hautpflege einzusetzen, [vgl. G.Imokawa et al., J.Soc. Cosmet. Che . 40. 273 (1989)].So far, the use of ceramides has been limited due to their lack of availability. There have therefore already been attempts to synthesize ceramide-analogous structures, so-called "synthetic barrier lipids (SBL)" or "pseudoceramides" and to use them for skin care, [cf. G. Imokawa et al., J. Soc. Cosmet. Che. 40, 273 (1989)].
So werden beispielsweise in den Europäischen Offenlegungs- schriften EP-A 0 277 641 und EP-A 0 227 994 (Kao) Ceramidana¬ loge der folgenden Struktur vorgeschlagen:
OH CH2CH2OHFor example, the European patent application EP-A 0 277 641 and EP-A 0 227 994 (Kao) Ceramidanaloge the following structure are proposed: OH CH2CH2OH
1 I R-0-CH2-CH-CH2-N-COR'.1 I R-0-CH2-CH-CH2-N-COR '.
Aus den Europäischen Offenlegungsschriften EP-A 0 482 860 und EP-A 0 495 624 (Unilever) sind ceramidverwandte Strukturen der folgenden Formel bekannt:Structures of the following formula, which are related to ceramides, are known from the European patent applications EP-A 0 482 860 and EP-A 0 495 624 (Unilever):
OR* R*OR * R *
I II I
R-O-CH2-CH-CH2-N-CO-(CH2)b(CHOR*)aR'.RO-CH2-CH-CH2-N-CO- (CH2) b (CHOR *) a R '.
Für den Schutz von Haut und Haaren werden in der Europäischen Patentanmeldung EP-A 0 455 429 (Unilever) ferner Zuckerderi¬ vate der folgenden Zusammensetzung vorgeschlagen:For the protection of skin and hair, sugar derivatives of the following composition are also proposed in European patent application EP-A 0 455 429 (Unilever):
Rb I Ra-O-(CH2)zCO-N-CH2-[Z]Rb IR a -O- (CH 2 ) z CO-N-CH 2 - [Z]
Hierbei steht Ra für Wasserstoff oder einen ungesättigten Fettacylrest, z für Zahlen von 7 bis 49, R-° für einen Hydroxy- alkyl- und Z für einen Zucker- oder Phosphatrest.Here, R a stands for hydrogen or an unsaturated fatty acyl radical, z for numbers from 7 to 49, R- ° for a hydroxyalkyl and Z for a sugar or phosphate radical.
Ungeachtet dieser Versuche ist der Erfolg, der sich mit diesen Stoffen erzielen läßt, bislang unbefiedigend; insbesondere wird das Leistungsvermögen natürlicher Ceramide nicht er¬ reicht. Ferner sind die Synthesesequenzen technisch aufwendig und daher kostspielig, was die Bedeutung der Substanzen zu¬ sätzlich relativiert.Despite these attempts, the success that can be achieved with these substances has so far been unsatisfactory; in particular, the performance of natural ceramides is not achieved. Furthermore, the synthesis sequences are technically complex and therefore expensive, which further relativizes the importance of the substances.
Die Aufgabe der vorliegenden Erfindung liegt darin, neue lei¬ stungsstarke ceramidanaloge Strukturen zu entwickeln, die sich durch eine möglichst einfache Synthese auszeichnen. Eine wei¬ tere Aufgabe besteht darin, neue Verbindungen mit einder
Struktur, die den Ceramiden bzw. den Pseudoceramiden sehr nahe kommt, auf Basis nicht-tierischer Rohstoffe herzustellen.The object of the present invention is to develop new high-performance ceramide-analog structures which are distinguished by the simplest possible synthesis. Another task is to create new connections with one another Manufacture structure that comes very close to ceramides or pseudoceramides on the basis of non-animal raw materials.
Beschreibung der ErfindungDescription of the invention
Gegenstand der Erfindung sind Oligohydroxycarbonsäurederivate der Formel IThe invention relates to oligohydroxycarboxylic acid derivatives of the formula I.
0 R3 O v 1 o0 R 3 O v 1 o
R1-X1-C-(CH)n-C-X2-R2 (I)R 1 -X 1 -C- (CH) n -CX 2 -R 2 (I)
worinwherein
R1 für einen linearen oder verzweigten Alkyl- und/oder Alke¬ nylrest mit 6 bis 30 Kohlenstoffatomen und R2 für einen li¬ nearen oder verzweigten Alkyl- und/oder Alkenylrest mit 1 bis 30 Kohlenstoffatomen, X1 und X2 gleich oder verschieden sind und für Sauerstoff oder eine R**-Gruppe, worin R"* Wasserstoff oder einen linearen oder verzweigten Alkylrest mit 1 bis 30 Kohlenstoffatomen bedeutet, R3 für Wasserstoff oder eine Hydroxygruppe und n für eine Zahl von 1 bis 5 stehen, mit der Maßgabe, daß, wenn n 1 ist, ist R3 eine Hydroxygruppe.R 1 for a linear or branched alkyl and / or alkenyl radical with 6 to 30 carbon atoms and R 2 for a linear or branched alkyl and / or alkenyl radical with 1 to 30 carbon atoms, X 1 and X 2 identical or different are and are oxygen or an R * * group, in which R "* is hydrogen or a linear or branched alkyl radical having 1 to 30 carbon atoms, R 3 is hydrogen or a hydroxyl group and n is a number from 1 to 5, with the Provided that when n is 1, R 3 is a hydroxy group.
Besonders bevorzugt sind Oligohydroxydicarbonsäurederivate der Formel I, in der R1 und R2 gleich oder verschieden sind und für einen linearen oder verzweigten Alkyl-und/oder Alkenylrest mit 12 bis 22 Kohlenstoffatomen, X1 und X2 für Sauerstoff, R3 für eine Hydroxygruppe und n für eine Zahl von 4 stehen.
Oligohydroxydicarboxylic acid derivatives of the formula I are particularly preferred, in which R 1 and R 2 are identical or different and for a linear or branched alkyl and / or alkenyl radical having 12 to 22 carbon atoms, X 1 and X 2 for oxygen, R 3 for a hydroxyl group and n stand for a number of 4.
Herstel1 erfahrenHerstel1 experienced
Ein weiterer Gegenstand der Erfindung betrifft ein Verfahren zur Herstellung von Oligohydroxydicarbonsäurederivaten der Formel IThe invention further relates to a process for the preparation of oligohydroxydicarboxylic acid derivatives of the formula I.
0 R3 O0 R 3 O
1 | II1 | II
Rl_χl_C-(CH)n-C-X2-R2 (I) R l_χl_C- (CH) n -CX 2 -R 2 (I)
worinwherein
R für einen linearen oder verzweigten Alkyl- und/oder Alke¬ nylrest mit 6 bis 30 Kohlenstoffatomen und R2 für einen li¬ nearen oder verzweigten Alkyl- und/oder Alkenylrest mit 1 bis 30 Kohlenstoffatomen, Xx und X2 gleich oder verschieden sind und für Sauerstoff oder eine NR^-Gruppe, worin R** Wasserstoff oder einen linearen oder verzweigten Alkylrest mit 1 bis 30 Kohlenstoffatomen bedeutet, R3 für Wasserstoff oder eine Hydroxygruppe und n für eine Zahl von 1 bis 5 stehen, mit der Maßgabe, daß, wenn n 1 ist, ist R3 eine Hydroxygruppe, welches dadurch gekennzeichnet ist, daß manR for a linear or branched alkyl and / or alkenyl radical with 6 to 30 carbon atoms and R 2 for a linear or branched alkyl and / or alkenyl radical with 1 to 30 carbon atoms, X x and X 2 are the same or different and for oxygen or an NR ^ group, in which R * * is hydrogen or a linear or branched alkyl radical having 1 to 30 carbon atoms, R 3 is hydrogen or a hydroxyl group and n is a number from 1 to 5, with the proviso that that when n is 1, R 3 is a hydroxy group, which is characterized in that
Oligohydroxydicarbonsäuren der Formel II,Oligohydroxydicarboxylic acids of the formula II,
O R3 O fl | II HO-C-(CH)n-C-OH (II)OR 3 O fl | II HO-C- (CH) n -C-OH (II)
worin R3 und n die oben angegebene Bedeutung haben, oder ein reaktives Derivat davon, in an sich bekannter Weise mit Verbindungen mit der Formel III und/oder IVwherein R 3 and n have the meaning given above, or a reactive derivative thereof, in a manner known per se with compounds of the formula III and / or IV
H-∑i-R1 (III)H-∑iR 1 (III)
H-X2-R2 (IV)
worin R1, R2, X1 tnd X2 die oben angegebenen Bedeutungen be¬ sitzen, umsetzt.HX 2 -R 2 (IV) in which R 1 , R 2 , X 1 and X 2 have the meanings given above.
AusganσsverbindungenOutgoing connections
Als Oligohydroxydicarbonsäuren, die unter die allgemeine For¬ mel II fallen, kommen solche mit 3 bis 7 Kohlenstoffatome und 1 bis 5 Hydroxygruppen in Betracht. Typische Beispiele sind Tartronsäure, Äpfelsäure, D-(-)-Weinsäure, L-(+)-Weinsäure, DL-Weinsäure, Glucarsäure, Schleimsäure, Mannozuckersäure, Arabinozuckersäure oder Heptaglucarsäure.Suitable oligohydroxydicarboxylic acids which come under general formula II are those having 3 to 7 carbon atoms and 1 to 5 hydroxyl groups. Typical examples are tartronic acid, malic acid, D - (-) - tartaric acid, L - (+) - tartaric acid, DL-tartaric acid, glucaric acid, mucic acid, mannosugaric acid, arabinosugaric acid or heptaglucaric acid.
Zur Herstellung der erfindungsgemäßen Verbindungen mit der allgemeinen Formel I werden die Dicarbonsäuren selbst oder deren reaktiven Derivate eingesetzt. Als reaktive Carbonsäu¬ re-Derivate kommen insbesondere die Lactone und die C1-C4-AI- kylester in Betracht. Zur Herstellung der entsprechenden Di- carbonsäureamide, d.h. wenn X1 und/oder X2 für eine NR^-Grup- pe stehen, ist es besonders vorteilhaft, die Oligohydroxydi¬ carbonsäuren in die entsprechenden C--C4-Alkylester zu über¬ führen. Diese Ester können in an sich bekannter Weise durch Veressterung der Säuren den Cι~C4-Alkoholen in Gegenwart eines Katalysators erhalten werden.To prepare the compounds of general formula I according to the invention, the dicarboxylic acids themselves or their reactive derivatives are used. Lactones and C1-C4-alkyl esters are particularly suitable as reactive carboxylic acid derivatives. For the preparation of the corresponding dicarboxamides, ie when X 1 and / or X 2 represent an NR ^ group, it is particularly advantageous to convert the oligohydroxydi carboxylic acids into the corresponding C 4 -C 4 alkyl esters. These esters can be obtained in a manner known per se by esterifying the acids in the C 1 -C 4 alcohols in the presence of a catalyst.
Die Oligohydroxydicarbonsäuren bzw. deren reaktiven Derivate werden in an sich bekannter Weise mit Verbindungen mit den Formeln III und/oder IV, umgesetzt, wobei die Verbindungen mit den Formeln III und IV gleich oder verschieden sein können. Die Menge Verbindungen III und IV wird üblicherweise so ausgewählt, daß im Endprodukt mit der Formel I mindestens ei¬ ner von R1 oder R2 ein Kohlenstoffrest mit mehr als 6, bevor¬ zugt mehr als 12 Kohlenstoffatomen, ist. Üblicherweise werden
die Oligohydroxydicarbonsäuren bzw. deren reaktiven Derivate und die Verbindungen mit den Formeln III und/oder IV in einem molaren Verhältnis von 1 : 0,9 bis 1 : 2,2 eingesetzt.The oligohydroxydicarboxylic acids or their reactive derivatives are reacted in a manner known per se with compounds of the formulas III and / or IV, it being possible for the compounds of the formulas III and IV to be identical or different. The amount of compounds III and IV is usually selected so that in the end product with the formula I at least one of R 1 or R 2 is a carbon radical having more than 6, preferably more than 12, carbon atoms. Usually will the oligohydroxydicarboxylic acids or their reactive derivatives and the compounds of the formulas III and / or IV are used in a molar ratio of 1: 0.9 to 1: 2.2.
Als Verbindungen mit den Formeln III und IV können entweder Alkohole, d.h. wenn X1 und X2 für Sauerstoff stehen, oder Amine, d.h. wenn X1 und X2 für eine Gruppe NR** stehen, einge¬ setzt werden.Either alcohols, ie when X 1 and X 2 are oxygen, or amines, ie when X 1 and X 2 are a group NR * *, can be used as compounds with the formulas III and IV.
Als Alkohole mit der Formel R-'-OH bzw. R2OH kommen insbesondere solche in Betracht, worin Rl bzw. R2 für einen linearen oder verzweigten Alkyl und/oder Alkenylrest mit 12 bis 22 Kohlen¬ stoffatomen steht. Typische Beispiele für geeignete Alkohole sind 1-,2-Hexadecanol, 1-Octadecanol, 9-Octadecen-l-ol 1-Te- tradecanol-, 1-Dodecanol-, 1-Isononol-, 1-Isotridecanol, 1-Oc- tanol, 2-Octanol-, Hexanol, 1-Eicosanol, 1-Heneicosanol, 1-Docosanol, 1-Nonanol, 1-Isononanol, 1-Isotridecanol, 1-Iso- octadecanol, besonders geeignet. Weitere geeignete Alkohole sind beispielsweise die nativen Fettalkohole auf pflanzlicher Basis wie z.B. Laurylalkohol, Myristylalkohol, Cetylalkohol, Stearylalkohol, Behenalkohol, Oleylalkohol, Elaidylalkohol, Ricinolalkohol, Linoleylalkohol, Linolenylalkohol sowie deren technischen Gemische, wie Kokosfettalkohol, Palm- und Palm¬ kernfettalkohol oder auch Erdnussfettalkohol.Alcohols with the formula R — OH and R 2 OH are in particular those in which R 1 and R 2 are linear or branched alkyl and / or alkenyl radical having 12 to 22 carbon atoms. Typical examples of suitable alcohols are 1-, 2-hexadecanol, 1-octadecanol, 9-octadecen-l-ol, 1-tetradecanol, 1-dodecanol, 1-isononol, 1-isotridecanol, 1-octanol , 2-octanol, hexanol, 1-eicosanol, 1-heneicosanol, 1-docosanol, 1-nonanol, 1-isononanol, 1-isotridecanol, 1-iso-octadecanol, particularly suitable. Other suitable alcohols are, for example, the native fatty alcohols based on plants, such as lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol, behen alcohol, oleyl alcohol, elaidyl alcohol, ricinol alcohol, linoleyl alcohol, linolenyl alcohol and their technical mixtures, such as coconut oil alcohol, palm fat and palm alcohol or also natural alcohol.
Als Amine mit den Verbindungen HNR1R4 und HNR2R4 sind insbe¬ sondere Alkylamine geeignet, worin R2 für einen linearen oder verzweigten Alkyl- und/oder Alkenylrest mit 12 bis 22 Kohlen¬ stoffatomen und R4 für Wasserstoff oder einen linearen oder verzweigten Alkylrest mit 1 bis 22 Kohlenstoffatomen bedeuten, sog. Fettamine. Als Beispiele können Fettamine, insbesondere primäre Fettalkylamine, wie Hexadecylamin, Octadecylamin, Dodecylamin, Decylamin oder Octylamin, aber auch Dialkylamine, wie Dioctadecylamin, Dihexadecylamin, sowie Guerbetamine, wie z. B. Methyloctadecylamin, genannt werden. Als technische
Fettamine kommen insbesondere solche auf pflanzlicher Basis wie Kokosamin, Palmkernamin oder Oleylamin sowie die Guerbetamine in Betracht.Particularly suitable amines with the compounds HNR 1 R 4 and HNR 2 R 4 are alkylamines, in which R 2 is a linear or branched alkyl and / or alkenyl radical having 12 to 22 carbon atoms and R 4 is hydrogen or a linear one or branched alkyl radical having 1 to 22 carbon atoms, so-called fatty amines. Examples include fatty amines, especially primary fatty alkylamines, such as hexadecylamine, octadecylamine, dodecylamine, decylamine or octylamine, but also dialkylamines, such as dioctadecylamine, dihexadecylamine, and Guerbetamines, such as. As methyloctadecylamine can be called. As a technical Fatty amines, in particular those based on plants, such as coconut amine, palm kernel amine or oleyl amine, and the Guerbet amines are suitable.
Die Kondensationsreaktion wird vorzugsweise bei Temperaturen im Bereich zwischen 20 und 95 °C in Gegenwart eines geeigneten Katalysators durchgeführt, wobei die Reaktionszeiten typi¬ scherweise bis 24 Stunden betragen können. Für die Umesterung der niederen Alkylester mit Fettalkoholen kommen sowohl basi¬ sche Katalysatoren wie NaOH, KOH, CH3θNa, C2HsONa als auch saure Katalysatoren wie H2SO4, p-Toluolsulfonsäure, Methansul- fonsäure, Phosphorsäure oder Amidosulfonsäure einesetzt wer¬ den. Als Lösungsmittel kommen beispielsweise Benzinfraktionen, 1,2-Dimethoxyethan, Aceton, Butanon, tert.-Butylmethylether oder Tetrahydrofuran in Betracht.The condensation reaction is preferably carried out at temperatures in the range from 20 to 95 ° C. in the presence of a suitable catalyst, the reaction times typically being up to 24 hours. Both basic catalysts such as NaOH, KOH, CH3θNa, C2HsONa and acidic catalysts such as H2SO4, p-toluenesulfonic acid, methanesulfonic acid, phosphoric acid or amidosulfonic acid are used for the transesterification of the lower alkyl esters with fatty alcohols. Examples of suitable solvents are gasoline fractions, 1,2-dimethoxyethane, acetone, butanone, tert-butyl methyl ether or tetrahydrofuran.
Im Falle der Aminolyse der niederen Alkylester mit Fettaminen kann ohne Katalysator oder mit basischen Katalysatoren wie CHßONa oder C2H5θ a gearbeitet werden.In the case of aminolysis of the lower alkyl esters with fatty amines, it is possible to work without a catalyst or with basic catalysts such as CHßONa or C2H5θ a.
Hautpf1ege i11e1Skin care i11e1
Ein weiterer Gegenstand der Erfindung betrifft Hautpflegemit¬ tel, enthaltend Oligohydroxydicarbonsäurederivate der Formel I.The invention further relates to skin care compositions containing oligohydroxydicarboxylic acid derivatives of the formula I.
Die erfindungsgemäßen Mittel können die Oligohydroxydicarbon- säurederivate in Mengen von 1 bis 50, vorzugsweise von 1 bis 30, insbesondere von 2 bis 10 Gew.-% - bezogen auf die Mittel - enthalten und dabei sowohl als "Wasser-in-öl" als auch "öl-in-Wasser"- Emulsionen vorliegen; weitere übliche Hilfs¬ und Zusatzstoffe können in Mengen von 5 bis 95, vorzugsweise 10 bis 80 Gew.-% enthalten sein. Ferner können die Formulie¬ rungen Wasser in einer Menge bis zu 99 Gew.-%, vorzugsweise 5 bis 80 Gew.-% aufweisen.
Als Trägeröle kommen hierzu beispielsweise in Betracht: Mine¬ ralöle, Pflanzenöle, Siliconöle, Fettsäureester, Dialkylether, Fettalkohole und Guerbetalkohole. Als Emulgatoren können bei¬ spielsweise eingesetzt werden: Sorbitanester, Monoglyceride, Polysorbate, Polyethylenglycolmono/difettsäureester, hocheth- oxylierte Fettsäureester sowie hochmolekulare Siliconverbin¬ dungen, wie z.B. Dimethylpolysiloxane mit einem durchschnitt¬ lichen Molekulargewicht von 10.000 bis 50.000. Weitere Zusatz¬ stoffe können sein: Konservierungsmittel wie z.B. p-Hydroxy- benzoesäureester; Ant oxidantien, wie z.B. Butylhydroxytoluol, Tocopherol: Feuchthaltemittel, wie z.B. Glycerin, Sorbiol. 2-Pyrrolidin-5-carboxylat, Dibutylphthalat, Gelatine, Poly- glycole mit einem durchschnittlichen Molekulargewicht von 200 bis 600; Puffer, wie z.B. Milchsäure/TEA oder Milchsäure/NaOH; milde Tenside, wie z.B. Alkyloligoglucoside, Fettal- koholethersulfate, Fettsäureisethionate, -tauride und -sarco- sinate, Ethercarbonsäuren, Sulfosuccinate, Eiweißhydrolysate bzw. -fettsäurekondensate, Sulfotriglyceride, kurzkettige Glu- camide; Phospholipide, Wachse, wie z.B. Bienenwachs, Ozoke- ritwachs, Paraffinwachs; Pflanzenextrakte, z.B. von Aloe vera; Verdickungsmittel; Färb- und Parfu stoffe, sowie Sonnenschutz- ittel, wie z.B. ultrafeines Titandioxid oder organische Stof¬ fe wie p-Aminobenzoesäure und deren Ester, Ethylhexyl-p-meth- oxyzimtsäureester, 2-Ethoxyethyl-p-methoxyzimtsäureester, Bu- tylmethoxydibenzoylmethan und deren Mischungen.The compositions according to the invention can contain the oligohydroxydicarboxylic acid derivatives in amounts of 1 to 50, preferably 1 to 30, in particular 2 to 10% by weight, based on the composition, both as "water-in-oil" and "oil-in-water" emulsions are present; further conventional auxiliaries and additives can be present in amounts of 5 to 95, preferably 10 to 80,% by weight. Furthermore, the formulations can contain water in an amount of up to 99% by weight, preferably 5 to 80% by weight. Suitable carrier oils include, for example: mineral oils, vegetable oils, silicone oils, fatty acid esters, dialkyl ethers, fatty alcohols and Guerbet alcohols. Examples of emulsifiers that can be used are: sorbitan esters, monoglycerides, polysorbates, polyethylene glycol mono / difatty acid esters, highly ethoxylated fatty acid esters and high molecular weight silicone compounds, such as dimethylpolysiloxanes with an average molecular weight of 10,000 to 50,000. Other additives can be: preservatives such as p-hydroxybenzoic acid ester; Antioxidants, such as butylated hydroxytoluene, tocopherol: humectants, such as glycerol, sorbiol. 2-pyrrolidine-5-carboxylate, dibutyl phthalate, gelatin, polyglycols with an average molecular weight of 200 to 600; Buffers such as lactic acid / TEA or lactic acid / NaOH; mild surfactants, such as, for example, alkyl oligoglucosides, fatty alcohol ether sulfates, fatty acid isethionates, taurides and sarcosinates, ether carboxylic acids, sulfosuccinates, protein hydrolyzates or fatty acid condensates, sulfotriglycerides, short-chain glucamids; Phospholipids, waxes such as beeswax, ozocerite wax, paraffin wax; Plant extracts, for example from aloe vera; Thickeners; Dyes and perfumes, and sunscreens, such as, for example, ultrafine titanium dioxide or organic substances, such as p-aminobenzoic acid and its esters, ethylhexyl-p-meth-oxycinnamate, 2-ethoxyethyl-p-methoxycinnamate, butyl methoxydibenzoylmethane and mixtures thereof .
In einer bevorzugten Ausführungsform der Erfindung können die Oligohydroxydicarbonsäurederivate mit konventionellen Cerami¬ den, Pseudoceramiden, Cholesterin, Cholesterinfettsäureestern, Fettsäuren, Triglyceriden, Cerebrosiden, Phospholipiden und ähnlichen Stoffen, abgemischt werden, wobei Liposomen entstehen können.
In einer weiteren bevorzugten Ausführungsform der Erfindung können die Oligohydroxydicarbonsäurederivate mit Wirkstoffbe¬ schleunigern, insbesondere mit etherischen ölen, wie bei¬ spielsweise Eucalyptol, Menthol und ähnlichen abgemischt wer¬ den.In a preferred embodiment of the invention, the oligohydroxydicarboxylic acid derivatives can be mixed with conventional ceramides, pseudoceramides, cholesterol, cholesterol fatty acid esters, fatty acids, triglycerides, cerebrosides, phospholipids and similar substances, liposomes being formed. In a further preferred embodiment of the invention, the oligohydroxydicarboxylic acid derivatives can be mixed with accelerators, in particular with essential oils, such as eucalyptol, menthol and the like.
In einer dritten bevorzugten Ausführungsform können die Oligo- hydroxydicarbonsäurederivate schließlich auch in Squalen oder Squalan gelöst und gegebenenfalls mit den anderen genannten Inhaltsstoffen zusammen mit flüchtigen oder nichtflüchtigen Siliconverbindungen als wasserfreie oder beinahe wasserfreie einphasige Systeme formuliert werden. Weitere Beispiele zu Be¬ standteilen und typischen Zusammensetzungen können bei¬ spielsweise der WO 90/01323 (Bernstein) und S.E. Friberg, J. Soc. Coε et. Chem. 41, 155 (1990) entnommen werden.
In a third preferred embodiment, the oligohydroxydicarboxylic acid derivatives can finally also be dissolved in squalene or squalane and optionally formulated with the other ingredients mentioned together with volatile or non-volatile silicone compounds as anhydrous or almost anhydrous single-phase systems. Further examples of constituents and typical compositions can be found, for example, in WO 90/01323 (Bernstein) and SE Friberg, J. Soc. Coε et. Chem. 41, 155 (1990).
Gewerbliche AnwendbarkeitIndustrial applicability
Die im Sinne der Erfindung als "synthetic barrier lipids" ein¬ zusetzenden Oligohydroxydicarbonsäurederivate stärken die na¬ türliche Barrierefunktion der Haut gegenüber äußeren Reizen. Sie verbessern Festigkeit, Geschmeidigkeit und Elastizität der Haut, steigern den Feuchtigkeitsgehalt und schützen die Haut vor Austrockung; zugleich werden feinste Falten geglättet.The oligohydroxydicarboxylic acid derivatives to be used as "synthetic barrier lipids" in the sense of the invention strengthen the natural barrier function of the skin against external stimuli. They improve the firmness, suppleness and elasticity of the skin, increase the moisture content and protect the skin from drying out; at the same time, the finest wrinkles are smoothed out.
Ein weiterer Gegenstand der Erfindung betrifft daher die Ver¬ wendung von Oligohydroxydicarbonsäurederivaten der Formel I als "synthetic barrier lipids" zur Herstellung von Hautpflege¬ mitteln, in denen sie in Mengen von 1 bis 50, vorzugsweise von 1 bis 30, insbesondere von 2 bis 10 Gew.-% - bezogen auf die Mittel - enthalten sein können. Aber auch spezielle For¬ mulierungen, die flüssigkristalline, lamellare Strukturen bil¬ den, sind zur Erhaltung der Barrierefunktion der Haut beson¬ ders vorteilhaft. Diese Formulierungen können angelehnt an die Zusammensetzung der Hornschichtlipide als Hauptbestandteile 5 Gew.-% bis 50 Gew.-% einer Verbindung mit der Formel I, 25 Gew.-% bis 75 Gew.-% gesättigte und ungesättigte Fettsäuren, deren Alkalisalze oder Gemische der Fettsäuren und ihren Sal¬ zen, 10 Gew.-% bis 50 Gew.-% Cholesterin, Phytosterine und/oder Cholesterylsulfat, 5 Gew.-% bis 30 Gew.-% Triglyce- ride (Triolein) und Wachsester, und 2 Gew.-% bis 20 Gew.-% Phospholide, wie Lecithine oder Kephaline, enthalten. Typische Beispiele für derartige Formulierungen sind Hautcremes, Softcremes, Nährcremes, Sonnenschutzcremes, Nachtcremes, Hautöle, Pflegelotionen und Körper-Aerosole.Another object of the invention therefore relates to the use of oligohydroxydicarboxylic acid derivatives of the formula I as "synthetic barrier lipids" for the production of skin care products in which they are used in amounts of 1 to 50, preferably 1 to 30, in particular 2 to 10 % By weight, based on the composition, may be present. However, special formulations which form liquid-crystalline, lamellar structures are also particularly advantageous for maintaining the barrier function of the skin. These formulations can be based on the composition of the horny layer lipids as main components 5% by weight to 50% by weight of a compound with the formula I, 25% by weight to 75% by weight of saturated and unsaturated fatty acids, their alkali metal salts or mixtures of the Fatty acids and their salts, 10% by weight to 50% by weight of cholesterol, phytosterols and / or cholesteryl sulfate, 5% by weight to 30% by weight of triglycerides (triolein) and wax esters, and 2% by weight. -% to 20 wt .-% phospholides such as lecithins or kephalins contain. Typical examples of such formulations are skin creams, soft creams, nutritional creams, sunscreen creams, night creams, skin oils, skin care lotions and body aerosols.
Die folgenden Beispiele sollen den Gegenstand der Erfindung näher erläutern, ohne ihn darauf einzuschränken.
BeispieleThe following examples are intended to explain the subject matter of the invention in more detail without restricting it. Examples
1) Schleimsäure-di-CiB/22-alkyles er1) Mucic acid di-CiB / 22-alkyls
Ein Gemisch aus 64,5g (0,2 Mol) Schleimsäuredibutylester, 119,4 g (0,4 Mol) des äquimolaren Gemisches aus Octadecanol und Docosanol und 0,5 g p-Toluolsulfonsäure wurde 12 Std. auf 90°C bei einem Druck von 50 mbar, erwärmt, gebildetes Butanol wurde gleichzeitig abdestilliert. Das Reaktionsgemisch wurde in Aceton gelöst, mit 0,3 g Natriumcarbonat verrührt und fil¬ triert. Das Filtrat wurde eingedampft und getrocknet. Es wur¬ den 146 g (95 % der Theorie) eines beige-farbenen Produkts erhalten, das einen Schmelzpunkt von 59 - 88°C hatte.A mixture of 64.5 g (0.2 mol) of mucic acid dibutyl ester, 119.4 g (0.4 mol) of the equimolar mixture of octadecanol and docosanol and 0.5 g of p-toluenesulfonic acid was at 90 ° C. under pressure for 12 hours of 50 mbar, heated, butanol formed was distilled off at the same time. The reaction mixture was dissolved in acetone, stirred with 0.3 g of sodium carbonate and filtered. The filtrate was evaporated and dried. 146 g (95% of theory) of a beige-colored product which had a melting point of 59-88 ° C. were obtained.
2) Schleimsäure-didodecylester a) Ein Gemisch aus 53,3 g (0,2 Mol) Schleimsäurediethylester und 74,5 g (0,4 Mol) Dodecanol wurde wie in Beispiel 1 umge¬ setzt. Es wurde ein fast farbloses harzartiges Produkt erhal¬ ten, das einen Schmelzpunkt von 92 - 115°C hatte.2) Mucic acid didodecyl ester a) A mixture of 53.3 g (0.2 mol) of diethyl mucic acid and 74.5 g (0.4 mol) of dodecanol was reacted as in Example 1. An almost colorless resin-like product was obtained which had a melting point of 92-115 ° C.
b) Ein Gemisch aus 64,5 g (0,2 Mol) Schleimsäurebutylester und 74,5 g (0,4 Mol) Dodecanol wurde analog dem Beispiel in analog der Patentschrift WO/PCT 93/02039 in 1,2-Dimethoxyethan in Gegenwart von Schwefelsäure erhalten. Es wurde ein fast farbloses wachsartiges Produkt erhalten, das einen Schmelz¬ punkt von 115 - 126°C hatte.b) A mixture of 64.5 g (0.2 mol) of mucic acid butyl ester and 74.5 g (0.4 mol) of dodecanol was prepared in the presence of 1,2-dimethoxyethane in analogy to the example in analogy to patent specification WO / PCT 93/02039 obtained from sulfuric acid. An almost colorless waxy product was obtained which had a melting point of 115-126 ° C.
3) Schleimsäure-di-Ci6/18-alkylester3) Mucic acid di-Ci6 / 18 alkyl ester
Ein Gemisch aus 64,5g (0,2 Mol) Schleimsäuredibutylester, 102,6 g (0,4 Mol) des äquimolaren Gemisches aus Hexadecanol und Octadecanol wurde analog dem Beispiel 2b hergestellt. Es wurde ein farbloses wachsartiges Produkt mit einem Schmelz¬ punkt von 100 - 112°C erhalten.
A mixture of 64.5 g (0.2 mol) of mucic acid dibutyl ester, 102.6 g (0.4 mol) of the equimolar mixture of hexadecanol and octadecanol was prepared analogously to Example 2b. A colorless waxy product with a melting point of 100-112 ° C. was obtained.
Claims
1. Oligohydroxycarbonsäurederivate der Formel I1. Oligohydroxycarboxylic acid derivatives of the formula I.
O R3 OOR 3 O
» i ' R1-X--—C-(CH)n-C-X2-R2 (I)»I 'R 1 -X --— C- (CH) n -CX 2 -R 2 (I)
worinwherein
R-*- für einen linearen oder verzweigten Alkyl- und/o der Alkenylrest mit 6 bis 30 Kohlenstoffatomen, und R2 für einen linearen oder verzweigten Alkyl- und/oder Alkenyl¬ rest mit 1 bis 30 Kohlenstoffatomen, X1 und X2 gleich oder verschieden sind und für Sauerstoff oder eine NR4- Gruppe, worin R4 Wasserstoff oder einen linearen oder verzweigten Alkylrest mit 1 bis 30 Kohlenstoffatomen be¬ deutet, R3 für Wasserstoff oder eine Hydroxygruppe und n für eine Zahl von 1 bis 5 stehen, mit der Maßgabe, daß, wenn n 1 ist, ist R3 eine Hydroxygruppe.R - * - for a linear or branched alkyl and / or the alkenyl radical with 6 to 30 carbon atoms, and R 2 for a linear or branched alkyl and / or alkenyl radical with 1 to 30 carbon atoms, X 1 and X 2 are the same or are different and are oxygen or an NR 4 group, in which R 4 is hydrogen or a linear or branched alkyl radical having 1 to 30 carbon atoms, R 3 is hydrogen or a hydroxyl group and n is a number from 1 to 5, with the proviso that when n is 1, R 3 is a hydroxy group.
2. Oligohydroxydicarbonsäurederivate nach Anspruch 1, da¬ durch gekennzeichnet, daß in der Formel I R1 und R2 einen Alykl- und/oder Alkenylrest mit 12 bis 18 Kohlenstoff¬ atomen, X**- und X2 Sauerstoff, R3 eine Hydroxygruppe und n 4 bedeuten.2. Oligohydroxydicarboxylic acid derivatives according to claim 1, da¬ characterized in that in the formula IR 1 and R 2 is an alkyl and / or alkenyl radical having 12 to 18 carbon atoms, X ** - and X 2 oxygen, R 3 is a hydroxy group and n 4 mean.
3. Verfahren zur Herstellung von Oligohydroxydicarbonsäure- derivaten mit der Formel I3. Process for the preparation of oligohydroxydicarboxylic acid derivatives with the formula I.
O R3 OOR 3 O
■ I *■ I *
Rl-χl_C-(CH)n-C-X2-R2 (I)Rl-χl_C- (CH) n -CX 2 -R 2 (I)
in der R1 und R2 gleich oder verschieden sind und für einen li¬ nearen oder verzweigten Alkyl- und/oder Alkenylrest mit 6 bis 30 Kohlenstoffatomen, X1 und X2 gleich oder verschie¬ den sind und für Sauerstoff oder eine NR4-Gruppe, worin R4 Wasserstoff oder linaren oder verzweigten Alkylrest mit 1 bis 30 Kohlenstoffatomen bedeutet, und n für eine Zahl von 0 bis 4 stehen, dadurch gekennzeichne , daß manin the R 1 and R 2 are the same or different and are the same or different for a linear or branched alkyl and / or alkenyl radical having 6 to 30 carbon atoms, X 1 and X 2 are the same and are different for oxygen or an NR 4 group, wherein R 4 is hydrogen or linear or branched alkyl radical having 1 to 30 carbon atoms, and n is a number from 0 to 4, characterized in that
Oligohydroxydicarbonsäuren der Formel II,Oligohydroxydicarboxylic acids of the formula II,
O R3 O H I u HO-C-(CH)n-C-OH (II)OR 3 OHI u HO-C- (CH) n -C-OH (II)
worin R3 und n die oben angegebene Bedeutung haben, oder ein reaktives Derivat davon, in an sich bekannt erwherein R 3 and n have the meaning given above, or a reactive derivative thereof, known per se
Weise mit Verbindungen mit der Formel III und/oder IVWay with compounds of formula III and / or IV
H-Xi-R1 (III)H-Xi-R 1 (III)
H-X2-R2 (IV)HX 2 -R 2 (IV)
worin R1, R2, X1 und X2 die oben angegebenen Bedeutu ngen besitzen, umsetzt.wherein R 1 , R 2 , X 1 and X 2 have the meanings given above, are implemented.
4. Verfahren nach Anspruch 3, dadurch gekennzeichnet, d aß man als reaktives Derivat der Oligohydroxydicarbonsäure mit der Formel II einen niederen Alkylester einsetzt.4. The method according to claim 3, characterized in that d ate a lower alkyl ester is used as the reactive derivative of oligohydroxydicarboxylic acid with the formula II.
5. Verfahren nach einem der Ansprüche 3 oder 4, dadurch ge¬ kennzeichnet, daß man als Oligohydroxydicarbonsäure mit der Formel II Tartronsäure, Äpfelsäure, D-(-)-Weinsäure, L-(+)-Weinsäure, DL-Weinsäure, Glucarsäure, Schleimsäure, Mannozuckersäure, Arabinozuckersäure oder Heptaglucarsäu- re einsetzt.5. The method according to any one of claims 3 or 4, characterized ge indicates that as the oligohydroxydicarboxylic acid with the formula II tartronic acid, malic acid, D - (-) - tartaric acid, L - (+) - tartaric acid, DL-tartaric acid, glucaric acid, Mucic acid, Mannosugaric acid, arabinosugaric acid or heptaglucaric acid.
6. Verfahren nach einem der Ansprüche 3 bis 5, dadurch ge¬ kennzeichnet, daß man als Verbindungen mit der Formel III oder IV Fettalkohole R---OH und/oder R20H einsetzt, worin R1 und R2 die in Anspruch 3 gegebene Bedeutungen haben.6. The method according to any one of claims 3 to 5, characterized ge indicates that one uses as compounds with the formula III or IV fatty alcohols R --- OH and / or R 2 0H, wherein R 1 and R 2 in claim 3 have given meanings.
7. Hautpflegemittel, enthaltend Oligohydroxydicarbonsäurede- rivate nach Anspruch 1.7. Skin care agent containing oligohydroxydicarboxylic acid derivatives according to claim 1.
8. Verwendung von Oligohydroxydicarbonsäurederivaten na ch Anspruch 1 als Bestandteil von "synthetic barrier lipids" zur Herstellung von Hautpflegemitteln. 8. Use of oligohydroxydicarboxylic acid derivatives according to claim 1 as a component of "synthetic barrier lipids" for the production of skin care products.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4424533.5 | 1994-07-12 | ||
DE19944424533 DE4424533A1 (en) | 1994-07-12 | 1994-07-12 | Oligohydroxydicarboxylic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996001799A1 true WO1996001799A1 (en) | 1996-01-25 |
Family
ID=6522931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1995/002563 WO1996001799A1 (en) | 1994-07-12 | 1995-07-03 | Oligohydroxydicarboxylic acid derivatives |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE4424533A1 (en) |
WO (1) | WO1996001799A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999042598A2 (en) | 1998-02-20 | 1999-08-26 | Zeneca Limited | Hybrid seed production |
US7157413B2 (en) | 2002-07-08 | 2007-01-02 | L'oreal | Detergent cosmetic compositions comprising an anionic surfactant, an amphoteric, cationic, and/or nonionic surfactant, and a polysacchardie, and use thereof |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2740035B1 (en) | 1995-10-20 | 1997-11-28 | Oreal | KERATINIC FIBER DYEING PROCESS AND COMPOSITION IMPLEMENTED DURING THIS PROCESS |
FR2740036B1 (en) | 1995-10-20 | 1997-11-28 | Oreal | NOVEL OXIDIZING COMPOSITION AND NEW PROCESS FOR PERMANENT DEFORMATION OR HAIR DECOLORATION |
FR2806274B1 (en) | 2000-03-14 | 2002-09-20 | Oreal | BALL APPLICATOR CONTAINING A HAIR COMPOSITION |
US6423376B1 (en) * | 2000-04-06 | 2002-07-23 | Air Products And Chemicals, Inc. | Tartaric acid diesters as biodegradable surfactants |
US6399543B1 (en) * | 2001-03-29 | 2002-06-04 | Air Products And Chemicals, Inc. | Low foam N,N′-dialkyltartaramide wetting agents |
US6413914B1 (en) | 2001-03-29 | 2002-07-02 | Air Products And Chemicals, Inc. | Low foam N,N′-dialkylmalamide wetting agents |
AU2002301803B2 (en) | 2001-11-08 | 2004-09-09 | L'oreal | Cosmetic compositions containing an aminosilicone and a conditioner, and uses thereof |
FR2831803B1 (en) | 2001-11-08 | 2004-07-30 | Oreal | COSMETIC COMPOSITIONS CONTAINING AN AMINO SILICONE AND A THICKENING AGENT AND THEIR USES |
US7879820B2 (en) | 2002-04-22 | 2011-02-01 | L'oreal S.A. | Use of a cyclodextrin as pearlescent agent and pearlescent compositions |
US8790623B2 (en) | 2005-01-18 | 2014-07-29 | Il'Oreal | Composition for treating keratin fibers, comprising at least one aromatic alcohol, at least one aromatic carboxylic acid, and at least one protecting agent |
FR2880801B1 (en) | 2005-01-18 | 2008-12-19 | Oreal | COMPOSITION FOR TREATING KERATIN FIBERS COMPRISING AROMATIC ALCOHOL, AROMATIC CARBOXYLIC ACID AND PROTECTIVE AGENT |
US7998464B2 (en) | 2005-09-29 | 2011-08-16 | L'oreal S.A. | Process for the photoprotective treatment of artificially dyed keratin fibers by application of a liquid water/steam mixture |
FR2915376B1 (en) | 2007-04-30 | 2011-06-24 | Oreal | USE OF A MULTI-CARBO COUPLING AGENT MULTI-GROUP SITES FOR PROTECTING THE COLOR FROM THE WASHING OF ARTIFICIALLY ARTIFICIENT KERATIN FIBERS; COLORING PROCESSES |
FR2920970B1 (en) | 2007-09-14 | 2010-02-26 | Oreal | COSMETIC COMPOSITIONS CONTAINING CATIONIC COPOLYMER, CYCLODEXTRIN AND SURFACTANT AND USES THEREOF. |
FR2920976B1 (en) | 2007-09-14 | 2009-12-04 | Oreal | COSMETIC COMPOSITION COMPRISING A CATIONIC COPOLYMER AND ANIONIC ASSOCIATIVE POLYMER AND COSMETIC PROCESSING METHOD. |
FR2920978B1 (en) | 2007-09-14 | 2012-04-27 | Oreal | COSMETIC COMPOSITION COMPRISING CATIONIC COPOLYMER AND STARCH AND METHOD OF COSMETIC TREATMENT. |
EP2111842A1 (en) | 2008-03-28 | 2009-10-28 | L'Oréal | Dyeing composition comprising ammonium chloride, method of colouring keratin fibres, and device |
EP2198850A1 (en) | 2008-12-22 | 2010-06-23 | L'oreal | Cosmetic composition containing four types of surfactants and one non-silicone fatty derivative |
FR2949970B1 (en) | 2009-09-15 | 2011-09-02 | Oreal | USE OF A SICCATIVE OIL FOR PROTECTING THE COLOR FROM THE WASHING OF KERATINIC FIBERS ARTIFICIALLY DYED; COLORING PROCESSES |
FR2973237A1 (en) | 2011-03-31 | 2012-10-05 | Oreal | FRACTIONAL COSMETIC TREATMENT PROCESS USING LASER OR MICRO-NEEDLES |
FR2985905B1 (en) | 2012-01-23 | 2014-10-17 | Oreal | COMPOSITION COMPRISING AT LEAST ONE PARTICULAR ALCOXYSILANE POLYMER |
FR2988602B1 (en) | 2012-03-27 | 2014-09-05 | Oreal | COSMETIC PROCESS OF CARE AND / OR MAKE-UP OF KERATINIC MATERIALS |
FR3001145B1 (en) | 2013-01-18 | 2015-07-17 | Oreal | FLEXIBLE SOLID COSMETIC COMPOSITION COMPRISING ANIO-NITIC SURFACTANTS AND POLYOLS, AND COSMETIC TREATMENT METHOD |
FR3001144B1 (en) | 2013-01-18 | 2015-07-17 | Oreal | FLEXIBLE SOLID COSMETIC COMPOSITION COMPRISING ANIONIC SURFACTANTS AND POLYMERIC CONDITIONING AGENTS, AND COSMETIC TREATMENT METHOD |
FR3001147B1 (en) | 2013-01-18 | 2015-07-17 | Oreal | FLEXIBLE SOLID COSMETIC COMPOSITION COMPRISING ANTI-ANSIAL SURFACTANTS AND SOLID PARTICLES, AND COSMETIC TREATMENT METHOD |
JP6510177B2 (en) | 2014-04-01 | 2019-05-08 | ロレアル | Compositions in the form of nano or microemulsions |
EP3137039B1 (en) | 2014-05-02 | 2020-08-12 | Hercules LLC | Personal care composition for a keratin substrate comprising conditioning and/or styling cationic tetra polymer |
JP6537788B2 (en) | 2014-06-25 | 2019-07-03 | ロレアル | Composition in the form of a nanoemulsion or microemulsion or having a lamellar structure |
JP2018087149A (en) | 2016-11-28 | 2018-06-07 | ロレアル | Composition in the form of a nano- or microemulsion |
JP2019196311A (en) | 2018-04-16 | 2019-11-14 | ロレアル | Composition in form of o/w type |
CN118973534A (en) | 2022-03-30 | 2024-11-15 | 莱雅公司 | Composition for caring for keratin materials |
WO2024197632A1 (en) | 2023-03-29 | 2024-10-03 | L'oreal | Composition for cleansing the skin |
FR3148912A1 (en) | 2023-05-24 | 2024-11-29 | L'oreal | COMPOSITION COMPRISING CATIONIC AND ANIONIC POLYMERS |
WO2025000434A1 (en) | 2023-06-30 | 2025-01-02 | L'oreal | Composition for conditioning the hair |
WO2025097289A1 (en) | 2023-11-07 | 2025-05-15 | L'oreal | Composition for caring for keratin materials |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2122716A (en) * | 1933-08-02 | 1938-07-05 | Du Pont | Hydroxy carboxylic acid esters of long chain alcohols |
DE878863C (en) * | 1950-12-16 | 1953-06-08 | Hoechst Ag | Process for the production of pearlescent or granular polymerization products |
US4078147A (en) * | 1975-09-10 | 1978-03-07 | The Nisshin Oil Mills, Ltd. | Hydroxy acid esters of higher alcohols |
EP0526301A1 (en) * | 1991-07-24 | 1993-02-03 | Agro Industrie Recherches Et Developpements (A.R.D.) | Alkyl galactarates, processes for their preparation and applications thereof |
-
1994
- 1994-07-12 DE DE19944424533 patent/DE4424533A1/en not_active Withdrawn
-
1995
- 1995-07-03 WO PCT/EP1995/002563 patent/WO1996001799A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2122716A (en) * | 1933-08-02 | 1938-07-05 | Du Pont | Hydroxy carboxylic acid esters of long chain alcohols |
DE878863C (en) * | 1950-12-16 | 1953-06-08 | Hoechst Ag | Process for the production of pearlescent or granular polymerization products |
US4078147A (en) * | 1975-09-10 | 1978-03-07 | The Nisshin Oil Mills, Ltd. | Hydroxy acid esters of higher alcohols |
EP0526301A1 (en) * | 1991-07-24 | 1993-02-03 | Agro Industrie Recherches Et Developpements (A.R.D.) | Alkyl galactarates, processes for their preparation and applications thereof |
Non-Patent Citations (1)
Title |
---|
PETER D. HOAGLAND: "The Formation of Intermediate Lactones During Aminolysis of Diethyl Galactarate", CARBOHYDRATE RESEARCH, vol. 98, AMSTERDAM NL, pages 203 - 208 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999042598A2 (en) | 1998-02-20 | 1999-08-26 | Zeneca Limited | Hybrid seed production |
EP2258856A1 (en) | 1998-02-20 | 2010-12-08 | Syngenta Limited | Hybrid seed production |
US7157413B2 (en) | 2002-07-08 | 2007-01-02 | L'oreal | Detergent cosmetic compositions comprising an anionic surfactant, an amphoteric, cationic, and/or nonionic surfactant, and a polysacchardie, and use thereof |
Also Published As
Publication number | Publication date |
---|---|
DE4424533A1 (en) | 1996-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996001799A1 (en) | Oligohydroxydicarboxylic acid derivatives | |
DE4420736C1 (en) | New pseudo-ceramide cpds. | |
EP0748328B1 (en) | Pseudoceramides | |
WO1996001807A1 (en) | Pseudoceramides and their use as skin care products | |
DE69320980T2 (en) | METHOD FOR PRODUCING CERAMIDES CONTAINING PHYTOSPHINGOSINE AND COSMETIC COMPOSITIONS CONTAINING THEM | |
DE4402929C1 (en) | Pseudoceramides, process for their preparation and their use | |
DE69107791T2 (en) | Cosmetics or pharmaceuticals or foodstuffs containing a dispersion of lipid vesicles. | |
DE69011402T2 (en) | Amide derivatives and skin preparations containing them. | |
DE10126253A1 (en) | Newly assembled quaternary ammonium compounds | |
DE3738406A1 (en) | SEBOSUPPRESSIVE TOPICAL PREPARATIONS | |
DE10126252A1 (en) | Quaternary ammonium compounds made up like nei | |
DE19916090A1 (en) | Skin care products | |
EP0231777A1 (en) | Moist keeping cosmetics and their use | |
DE4326959C2 (en) | Use of fatty acid N-alkylpolyhydroxyalkylamides | |
DE69501991T2 (en) | LINOLEOYLAMIDE CERAMIDE DERIVATIVE AND ITS USE IN COSMETIC PREPARATIONS FOR TREATING DRY SKIN | |
DE602004002517T2 (en) | Water-in-oil emulsions containing a sphingosine and a fatty acid | |
EP1178044B1 (en) | Tocopherylalkoxylates, their preparation and their use in cosmetic and pharmaceutical forms | |
DE19523479C1 (en) | Synthetic ceramide barrier lipid cpds. for use in skin or hair care prods. e.g. moisturising agents | |
DE4326958C2 (en) | Use of fatty acid N-alkylglycosylamides | |
DE69524720T2 (en) | DERMATOLOGICAL PREPARATIONS | |
DE19652302C1 (en) | Stable, homogeneous cosmetic skin care preparation | |
DE4403258C1 (en) | Pseudoceramides | |
DE2351864C3 (en) | Deodorizing cosmetic agent | |
DE4404175C1 (en) | Pseudoceramides | |
DE4430851C1 (en) | New di:carboxylic acid ester(s) contg. di:acyloxy:propyl residue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |